We do not support your browser. Please take a moment and upgrade to the most recent version of Internet Explorer.
Education & Training


Commercialization

Anderson School Courses

Business Plan Development (295D). Anderson School students are required to develop a business plan for a specific technology. Faculty innovators may submit their technologies for consideration. For more information contact:

George Abe
Lecturer and Faculty Director, Strategic Management Research Program
UCLA Anderson School of Management
george.abe@anderson.ucla.edu

Business of Science

The Business of Science Center has three initiatives that are focused on entrepreneurship and product development and commercialization.

  • Advancing Bioengineering Innovations is a fellowship for graduate students from any doctorial or professional program at UCLA. Fellows identify and develop solutions for unmet medical needs in the UCLA Health System.
  • The Venture Team Program pairs biomedical faculty with graduate students from the Anderson School of Management. The teams received mentorship and training as they compete for proof-of-concept funds to advance their innovation toward licensing.
  • Business of Science Certificate Program provides training in entrepreneurship, new product development, and commercialization.

Additional information about Business of Science programs can be found here:
http://www.bs.pharmacology.ucla.edu/

California NanoSystems Institute (CNSI) Entrepreneurship Forum

CNSI's Entrepreneurship Forum is designed to enable entrepreneurial UCLA faculty, staff and students to exchange ideas and build relationships within the LA entrepreneurial ecosystem. The forum serves CNSI's mission to facilitate commercialization by creating an environment where innovative ideas can be shared and cultivated into commercial opportunities.

For more information and to view the recorded lectures, please go to the CNSI Entrepreneurship Forum.

Center for Accelerated Innovation

The University of California Center for Accelerated Innovation (UC CAI) advances early-stage drugs, devices and diagnostics toward commercialization to benefit patients with heart, lung and blood diseases. Innovators receive pilot funds, mentorship and project-management support to develop their technologies. Three to six pilot grants of up to $200K are awarded annually.

UC CAI is part of a prestigious, national consortium of academic innovators that includes Harvard University and Cleveland Clinic. It receives support from the National Heart, Lung and Blood Institute (NHLBI).

For more information, please go to the UC CAI website.

Consultation Services

CTSI consultants meet one-on-one with faculty innovators to provide advice about drug development, intellectual property, agreements with industry and venture capital. To schedule an appointment with one of our consultants, please send a request to uccai-consults@ctsi.ucla.edu

  • Michael (Mike) Palazzolo, MD, PhD is a UCLA professor of medicine with managerial experience in academia and biotechnology industry. He was formerly Senior Director of Biosystems at Amgen, with oversight of 270 scientists engaged in high-throughput genomics research. He also previously worked in venture capital. His expertise includes:
    • Small molecule drug development
    • Connecting faculty to experts in the development of medical devices and diagnostics

  • William (Bill) Boyle, PhD is a UCLA professor of medicine who has been a founder, executive, board member and scientific advisor to various biotechnology companies. He was formerly Director of Discovery Research and the Biosystems technology platforms at Amgen, where he led a basic research effort as part of the preclinical and clinical development of OPG and derivative RANKL antagonists, including denosumab, a monoclonal antibody therapeutic approved for osteoporosis and bone metastasis. His expertise includes:
    • Small molecule and antibody drug development
    • SBIR/STTR funding

Guides, Seminars and Workshops

UC Center for Accelerated Innovation (UC CAI)
Entrepreneurship Training by Campus  - this is extensive collection of entrepreneurship training and resources available at the five UC health campuses (UC Davis, UC Irvine, UCLA, UC San Diego and UCSF) and across the national CAI partners.

Technology Commercialization Primer - developed by Vish Krishnan, leader of the UC CAI Skills Development Program.

Therapeutic Discovery & Development Series - this series address capital and time, business development and Intellectual Property.

NSF I-Corps - learn more about the NSF Innovation Corps, or I-Corps, program available. 



"Entrepreneur's Guide to a Biotech Startup" by Peter Kolchinsky, PhD

Dr. Kolchinsky performs due diligence on investment opportunities at RA Capital Associates, a biotech-focused public equity fund. He works closely with Richard Aldrich, a founding employee and former CBO of Vertex Pharmaceuticals. Dr. Kolchinsky’s free guide can be found at www.evelexa.com, an online resource for biotech investors and entrepreneurs that he launched in 2001.

Technology Transfer

Research often leads to discoveries and inventions with commercial potential. These discoveries or inventions may comprise intellectual property that would benefit from protection through patents, copyright, and occasionally trademarks. Technology transfer is the process of transitioning technologies from the research lab to the marketplace.

At UCLA, the Office of Intellectual Property and Industry-Sponsored Research (OIP-ISR) assists with the technology transfer process. Early contact with the office about an invention is important. To learn more about the technology transfer process, visit the OIP-ISR website.

Consultation Services

CTSI consultants meet one-on-one with faculty innovators to provide advice about drug development, intellectual property, agreements with industry and venture capital. To schedule an appointment with one of our consultants, please send a request to uccai-consults@ctsi.ucla.edu

  • Michael (Mike) Palazzolo, MD, PhD is a UCLA professor of medicine with managerial experience in academia and biotechnology industry. He was formerly Senior Director of Biosystems at Amgen, with oversight of 270 scientists engaged in high-throughput genomics research. He also previously worked in venture capital. His expertise includes:
    • Small molecule drug development
    • Connecting faculty to experts in the development of medical devices and diagnostics

  • William (Bill) Boyle, PhD is a UCLA professor of medicine who has been a founder, executive, board member and scientific advisor to various biotechnology companies. He was formerly Director of Discovery Research and the Biosystems technology platforms at Amgen, where he led a basic research effort as part of the preclinical and clinical development of OPG and derivative RANKL antagonists, including denosumab, a monoclonal antibody therapeutic approved for osteoporosis and bone metastasis. His expertise includes:
    • Small molecule and antibody drug development
    • SBIR/STTR funding

Guides, Seminars and Workshops

UC Center for Accelerated Innovation (UC CAI)
Entrepreneurship Training by Campus  - this is extensive collection of entrepreneurship training and resources available at the five UC health campuses (UC Davis, UC Irvine, UCLA, UC San Diego and UCSF) and across the national CAI partners.

Technology Commercialization Primer - developed by Vish Krishnan, leader of the UC CAI Skills Development Program.

Therapeutic Discovery & Development Series - this series address capital and time, business development and Intellectual Property.

NSF I-Corps - learn more about the NSF Innovation Corps, or I-Corps, program available. 



"Entrepreneur's Guide to a Biotech Startup" by Peter Kolchinsky, PhD

Dr. Kolchinsky performs due diligence on investment opportunities at RA Capital Associates, a biotech-focused public equity fund. He works closely with Richard Aldrich, a founding employee and former CBO of Vertex Pharmaceuticals. Dr. Kolchinsky’s free guide can be found at www.evelexa.com, an online resource for biotech investors and entrepreneurs that he launched in 2001.

Consultation Services

CTSI consultants meet one-on-one with faculty innovators to provide advice about drug development, intellectual property, agreements with industry and venture capital. To schedule an appointment with one of our consultants, please send a request to uccai-consults@ctsi.ucla.edu

  • Michael (Mike) Palazzolo, MD, PhD is a UCLA professor of medicine with managerial experience in academia and biotechnology industry. He was formerly Senior Director of Biosystems at Amgen, with oversight of 270 scientists engaged in high-throughput genomics research. He also previously worked in venture capital. His expertise includes:
    • Small molecule drug development
    • Connecting faculty to experts in the development of medical devices and diagnostics

  • William (Bill) Boyle, PhD is a UCLA professor of medicine who has been a founder, executive, board member and scientific advisor to various biotechnology companies. He was formerly Director of Discovery Research and the Biosystems technology platforms at Amgen, where he led a basic research effort as part of the preclinical and clinical development of OPG and derivative RANKL antagonists, including denosumab, a monoclonal antibody therapeutic approved for osteoporosis and bone metastasis. His expertise includes:
    • Small molecule and antibody drug development
    • SBIR/STTR funding

Guides, Seminars and Workshops

UC Center for Accelerated Innovation (UC CAI)
Entrepreneurship Training by Campus  - this is extensive collection of entrepreneurship training and resources available at the five UC health campuses (UC Davis, UC Irvine, UCLA, UC San Diego and UCSF) and across the national CAI partners.

Technology Commercialization Primer - developed by Vish Krishnan, leader of the UC CAI Skills Development Program.

Therapeutic Discovery & Development Series - this series address capital and time, business development and Intellectual Property.

NSF I-Corps - learn more about the NSF Innovation Corps, or I-Corps, program available. 



"Entrepreneur's Guide to a Biotech Startup" by Peter Kolchinsky, PhD

Dr. Kolchinsky performs due diligence on investment opportunities at RA Capital Associates, a biotech-focused public equity fund. He works closely with Richard Aldrich, a founding employee and former CBO of Vertex Pharmaceuticals. Dr. Kolchinsky’s free guide can be found at www.evelexa.com, an online resource for biotech investors and entrepreneurs that he launched in 2001.

Consultation Services

CTSI consultants meet one-on-one with faculty innovators to provide advice about drug development, intellectual property, agreements with industry and venture capital. To schedule an appointment with one of our consultants, please send a request to uccai-consults@ctsi.ucla.edu

  • Michael (Mike) Palazzolo, MD, PhD is a UCLA professor of medicine with managerial experience in academia and biotechnology industry. He was formerly Senior Director of Biosystems at Amgen, with oversight of 270 scientists engaged in high-throughput genomics research. He also previously worked in venture capital. His expertise includes:
    • Small molecule drug development
    • Connecting faculty to experts in the development of medical devices and diagnostics

  • William (Bill) Boyle, PhD is a UCLA professor of medicine who has been a founder, executive, board member and scientific advisor to various biotechnology companies. He was formerly Director of Discovery Research and the Biosystems technology platforms at Amgen, where he led a basic research effort as part of the preclinical and clinical development of OPG and derivative RANKL antagonists, including denosumab, a monoclonal antibody therapeutic approved for osteoporosis and bone metastasis. His expertise includes:
    • Small molecule and antibody drug development
    • SBIR/STTR funding

Guides, Seminars and Workshops

UC Center for Accelerated Innovation (UC CAI)
Entrepreneurship Training by Campus  - this is extensive collection of entrepreneurship training and resources available at the five UC health campuses (UC Davis, UC Irvine, UCLA, UC San Diego and UCSF) and across the national CAI partners.

Technology Commercialization Primer - developed by Vish Krishnan, leader of the UC CAI Skills Development Program.

Therapeutic Discovery & Development Series - this series address capital and time, business development and Intellectual Property.

NSF I-Corps - learn more about the NSF Innovation Corps, or I-Corps, program available. 


"Entrepreneur's Guide to a Biotech Startup" by Peter Kolchinsky, PhD

Dr. Kolchinsky performs due diligence on investment opportunities at RA Capital Associates, a biotech-focused public equity fund. He works closely with Richard Aldrich, a founding employee and former CBO of Vertex Pharmaceuticals. Dr. Kolchinsky’s free guide can be found at www.evelexa.com, an online resource for biotech investors and entrepreneurs that he launched in 2001.

NHLBI Small Biz Regulatory Hangouts

Below are the links to the Small Biz Regulatory Hangouts that have been delivered and archived to You Tube
• Navigating the FDA website http://bit.ly/QYjYeB
• First Contact with FDA http://bit.ly/UqFRo7